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Abstract 
Short communication on POU1F1, with data on 
DNA/RNA, on the protein encoded and where the 
gene is implicated. 
Identity 
Other names: CPHD1, GHF-1, PIT1, POU1F1a, 
Pit-1 
HGNC (Hugo): POU1F1 
Location: 3p11.2 
DNA/RNA 
Note 
The anterior pituitary-specific transcription factor 
POU1F1 was initially identified and cloned as a 
transactivator of prolactin (PRL), growth hormone 
(GH), and TSHβ-subunit genes (Bodner et al., 
1988; Ingraham et al., 1988). Transcription 
produces 2 alternatively spliced mRNAs α 
(NM_000306.2) and β (NM_001122757.1). 
Description 
The human POU1F1 gene is composed of 6 exons 
(Theill et al., 1992). 
Transcription 
Two transcripts have been reported for this gene. 
Protein 
Description 
The main protein isoform expressed in pituitary 
cells is POU1F1α.  
This isoform, also named PIT-1.b or PIT-1α, has 
291 aa.  
The predicted protein corresponding to POU1F1β, 
also named PIT-1.a or PIT-1β, has 317 aa and acts 
as a repressor in pituitary cells (Theill et al., 1992; 
Jonsen et al., 2009). POU1F1 is structurally related 
to the POU family of transcriptional regulators, 
containing a characteristic POU domain divided 
into two regions, the POU-specific and homeo 
subdomains. 
 
Structure of POU1F1 gene and its transcripts encoded on minus strand of chromosome 3. 
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The POUs-specific domain consists of 75 amino 
acids, comprises 4 α-helices, and contributes to the 
DNA binding specificity and protein / protein 
interactions (Ingraham et al., 1990; Jacobson et al., 
1997). The homeodomain is composed of 60 amino 
and contains 3 α-helices. The N-terminal part of 
POU1F1 is involved in the transcriptional activity. 
POU1F1 binds as a dimer to most DNA response 
elements (for review see Phillips and Luisi, 2000). 
Expression 
The expression of POU1F1 is largely restricted in 
the pituitary gland in somato- thyreo- and lacto-
trope cells, but this factor is also expressed in some 
extrapituitary tissues and cell lines, including the 
mammary gland (Gil-Puig et al., 2002). 
Localisation 
The localization of POU1F1 is nuclear. 
Function 
POU1F1 is a member of the POU family of 
transcription factors. This factor is required for 
terminal differentiation of the somatotrope, 
lactotrope and thyrotrope cell types (Ingraham et 
al., 1988; Cohen et al., 1996). This factor is also 
implicated in the cell growth and prevents the 
apoptotic cell death (Pellegrini et al., 2006). 
Mutations 
Note 
In humans, mutation in the POU1F1 gene has been 
shown to be responsible for combined pituitary 
hormone deficiency (for review see Quentien et al., 
2006) (see below). 
Implicated in 
Pituitary adenoma 
Prognosis 
POU1F1 is overexpressed in GH, PRL and TSH 
pituitary adenomas (Asa et al., 1993; Delhase et al., 
1993; Pellegrini et al., 1994) and the increased 
expression in adenomas is compatible with the role 
of POU1F1 in cell proliferation. Interestingly, 
human non-functioning pituitary adenomas also 
express POU1F1, especially it was expressed in all 
alpha SU positive nonfunctioning adenomas 
(Osamura et al., 1999). 
Combined pituitary hormone 
deficiency (CPHD) 
Prognosis 
In humans, mutation in the POU1F1 gene has been 
shown to be responsible for combined pituitary 
hormone deficiency. This syndrome is a disease 
characterized by the lack of PRL, GH, and TSHbeta 
produced by the somato- lacto- and thyreo-tropes 
cells. At least sixteen distinct recessive or dominant 
POU1F1 mutations have been described to date 
(Cushman et al., 2002; Dattani, 2005). The 
molecular mechanisms underlying their effects can 
be dominant inhibition of transcription or inability 
to bind to DNA. The R271W mutation is the most 
commonly occurring POU1F1 gene defect 
(Radovick et al., 1992). Other mutations, such as 
F135C, show a decreased transactivation activity 
although the DNA binding property is conserved 
(Vallette-Kasic et al., 2001). 
 
Location of the Pit-1 gene mutation. 
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Breast carcinoma 
Prognosis 
POU1F1 was expressed in normal human breast 
tissue but its mRNA expression levels is 
significantly higher in breast adenocarcinoma. This 
deregulation promotes tumor growth and metastasis 
(Gil-Puig et al., 2005; Ben-Batalla et al., 2010). 
Acute myeloid leukemia 
Prognosis 
In acute myeloid leukemia POU1F1 has been 
identified as a new fusion partner of NUP98 gene 
(Lisboa et al., 2013). 
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